Cytokine gene polymorphisms in psoriasis
- 1 April 2001
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (4) , 849-853
- https://doi.org/10.1046/j.1365-2133.2001.04143.x
Abstract
Background Cytokine production is under genetic control, and certain allelic variants of cytokine genes are associated with higher or lower cytokine production in vitro and in vivo. Psoriasis is associated with an overexpression in the involved skin of T‐helper cell type 1 (Th1) cytokines, e.g. interferon (IFN) ‐γ and tumour necrosis factor (TNF) α and relative underexpression of Th2 cytokines, e.g. interleukin (IL) ‐4 and IL‐10. Objective We investigated the hypothesis that allelic variants of genes for a high production of Th1 cytokines or TNF‐α, or conversely low production of Th2 cytokines might represent a risk factor for developing psoriasis. Methods Genotyping for IFN‐γ, IL‐10, IL‐4 and TNF‐α was undertaken for 84 patients with psoriasis and compared with control data on file. Results Genotype frequencies showed no differences between patients and controls for IFN‐γ, TNF‐α or IL‐4. For IL‐10, patients with late onset psoriasis (over 40 years) were more likely to be heterozygous at position − 1082 (P = 0·02), corresponding to intermediate production of IL‐10 in vitro and in vivo. Conclusions Psoriasis is not determined by a genotype consistent with high production of Th1 cytokines or low production of Th2 cytokines. Thus, the Th1 cytokine profile found in psoriatic plaques is most likely a consequence of local factors.Keywords
This publication has 37 references indexed in Scilit:
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology, 1998
- The Th1/Th2 paradigmImmunology Today, 1997
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Disease concomitance in psoriasisJournal of the American Academy of Dermatology, 1995
- Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients relationships with disease severityClinical and Experimental Dermatology, 1994
- Systemic tumour necrosis factor (TNF) treatment in psoriasis: clinical data from a total of 14 patients in an open trialJournal of Dermatological Treatment, 1994
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Response to tumor necrosis factor in two cases of psoriasisJournal of the American Academy of Dermatology, 1991
- Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factorJournal of the American Academy of Dermatology, 1989